Your browser doesn't support javascript.
loading
Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett's Esophagus Screening.
Baldwin-Hunter, Brittany L; Knotts, Rita M; Leeds, Samantha D; Rubenstein, Joel H; Lightdale, Charles J; Abrams, Julian A.
Afiliação
  • Baldwin-Hunter BL; Division of Digestive and Liver Diseases, Columbia University Medical Center, 630 W 168th Street, P&S 3-401, New York, NY, 10032, USA.
  • Knotts RM; Division of Gastroenterology and Hepatology, New York University School of Medicine, 240 East 38th Street, 23rd Floor, New York, NY, 10016, USA.
  • Leeds SD; Division of Digestive and Liver Diseases, Columbia University Medical Center, 630 W 168th Street, P&S 3-401, New York, NY, 10032, USA.
  • Rubenstein JH; Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA.
  • Lightdale CJ; Barrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Taubman Center, Floor 3 Reception D, 1500 E Medical Center Dr SPC 2435, Ann Arbor, MI, 48109-2435, USA.
  • Abrams JA; Division of Digestive and Liver Diseases, Columbia University Medical Center, 630 W 168th Street, P&S 3-401, New York, NY, 10032, USA.
Dig Dis Sci ; 64(12): 3463-3470, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31273597
ABSTRACT

BACKGROUND:

Clinical prediction models targeting patients for Barrett's esophagus (BE) screening include data obtained by interview, questionnaire, and body measurements. A tool based on electronic health records (EHR) data could reduce cost and enhance usability, particularly if combined with non-endoscopic BE screening methods.

AIMS:

To determine whether EHR-based data can identify BE patients.

METHODS:

We performed a retrospective review of patients ages 50-75 who underwent a first-time esophagogastroduodenoscopy. Data extracted from the EHR included demographics and BE risk factors. Endoscopy and pathology reports were reviewed for histologically confirmed BE. Screening criteria modified from clinical guidelines were assessed for association with BE. Subsequently, a score based on multivariate logistic regression was developed and assessed for its ability to identify BE subjects.

RESULTS:

A total of 2931 patients were assessed, and BE was found in 1.9%. Subjects who met screening criteria were more likely to have BE (3.3% vs. 1.1%, p = 0.001), and the criteria predicted BE with an AUROC of 0.65 (95% CI 0.59-0.71). A score based on logistic regression modeling included gastroesophageal reflux disease, sex, body mass index, and ever-smoker status and identified BE subjects with an AUROC of 0.71 (95% CI 0.64-0.77). Both prediction tools produced higher AUROCs in women than in men.

CONCLUSIONS:

EHR-based BE risk prediction tools identify BE patients with fair accuracy. While these tools may improve the efficiency of patient targeting for BE screening in the primary care setting, challenges remain to identify high-risk patients for non-invasive BE screening in clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Refluxo Gastroesofágico / Obesidade Abdominal / Registros Eletrônicos de Saúde / Fumar Cigarros Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Refluxo Gastroesofágico / Obesidade Abdominal / Registros Eletrônicos de Saúde / Fumar Cigarros Idioma: En Ano de publicação: 2019 Tipo de documento: Article